Navigation Links
European Commission's Joint Research Centre's annual report 2010
Date:5/6/2011

This report provides an overview of the activities, accomplishments and resources related to the JRC's work carried out during 2010 and includes figures on staff, budget and publications.

In her foreword, Commissioner Mire Geoghegan-Quinn, in charge of research, innovation and science, highlights the need for policy making based on the best possible advice and affirms that "the JRC has built an excellent reputation as a world-class provider of scientific and technical support to European policy makers and legislators". The Commissioner refers as well to the role of the JRC as a "trusted and truly independent voice advising us on what is on the horizon in order to take timely policy decisions".

JRC Director-General, Dominique Ristori, emphasizes JRC efforts to support the Europe 2020 policy priorities addressing major challenges such as health, safety and security.

Examples of JRC's results throughout the year are described, such as the European-wide electricity grid model, contributions to the car emissions regulations, the crisis response work to Haiti and the methods to measure mycotoxins in infant food.

Many other highlights of JRC's work in different areas, such as energy (including nuclear), safety of food and consumer products, open and competitive economy or sustainable management of natural resources can also be found in the report.

In addition, an overview is given of the JRC mission and its implementation, the scientific activities and relations with the outside world. It covers as well the JRC input to the various stages of the policy cycle: from anticipation and formulation to policy adoption, implementation and evaluation.


'/>"/>

Contact: Elena Gonzalez Verdesoto
elena.gonzalez-verdesoto@ec.europa.eu
322-299-9862
European Commission Joint Research Centre
Source:Eurekalert

Page: 1

Related biology technology :

1. Cyberonics Announces First Implant of AspireSR™ Seizure Response Product in European Trial
2. Saladax Biomedical, Inc. Announces European Commercialization Team
3. ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
4. European Commission Approves DuPont Tender Offer to Acquire Danisco
5. Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
8. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
9. Reportlinker Adds Strategic Analysis of European Human Machine Interface (HMI) Market
10. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
11. European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Research and Markets has announced the addition ... to their offering. ... The study scope includes ... chassis organisms, synthetic cells, production systems), enabling technologies (DNA ... specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, agriculture) ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... utilize LungDirect for pulmonary nodule patient management. In addition ... or a spot on the lung, UCHealth looks to ... manual data entry. Stephanie Brown, RN ... my nodule patients with an Excel spreadsheet, which was ...
(Date:2/16/2017)... WARRINGTON, Pa. , Feb. 16, 2017 /PRNewswire/ ... a biotechnology company focusing on developing aerosolized KL4 ... data from a preclinical influenza study showed that ... overall survival in a well-established preclinical animal model. ... to a growing body of evidence that supports ...
(Date:2/15/2017)... ... , ... Executive search firm, Slone Partners, announces the placement ... is a veteran life sciences and molecular diagnostics executive with extensive commercialization experience. ... disease risk in future generations. In his new role, Matt will be responsible ...
Breaking Biology Technology:
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)...  EyeLock LLC, a market leader of iris-based identity ... What You Should Know About Biometrics in the Cloud ... is a growing concern. In traditional schemes, cryptography is ... authentication schemes such as username/password suffer from inherent weaknesses. ... an elegant solution to the problem of high-security user ...
Breaking Biology News(10 mins):